1. Home
  2. KRO vs RCUS Comparison

KRO vs RCUS Comparison

Compare KRO & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRO
  • RCUS
  • Stock Information
  • Founded
  • KRO 1916
  • RCUS 2015
  • Country
  • KRO United States
  • RCUS United States
  • Employees
  • KRO N/A
  • RCUS N/A
  • Industry
  • KRO Major Chemicals
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRO Industrials
  • RCUS Health Care
  • Exchange
  • KRO Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • KRO 1.1B
  • RCUS 1.2B
  • IPO Year
  • KRO N/A
  • RCUS 2018
  • Fundamental
  • Price
  • KRO $8.75
  • RCUS $11.07
  • Analyst Decision
  • KRO Hold
  • RCUS Buy
  • Analyst Count
  • KRO 3
  • RCUS 11
  • Target Price
  • KRO $12.00
  • RCUS $31.11
  • AVG Volume (30 Days)
  • KRO 128.9K
  • RCUS 1.1M
  • Earning Date
  • KRO 03-05-2025
  • RCUS 02-25-2025
  • Dividend Yield
  • KRO 2.28%
  • RCUS N/A
  • EPS Growth
  • KRO N/A
  • RCUS N/A
  • EPS
  • KRO 0.82
  • RCUS N/A
  • Revenue
  • KRO $1,864,100,000.00
  • RCUS $263,000,000.00
  • Revenue This Year
  • KRO $25.77
  • RCUS $127.65
  • Revenue Next Year
  • KRO $6.54
  • RCUS N/A
  • P/E Ratio
  • KRO $10.71
  • RCUS N/A
  • Revenue Growth
  • KRO 15.87
  • RCUS 119.17
  • 52 Week Low
  • KRO $8.51
  • RCUS $10.63
  • 52 Week High
  • KRO $14.50
  • RCUS $20.31
  • Technical
  • Relative Strength Index (RSI)
  • KRO 29.14
  • RCUS 34.34
  • Support Level
  • KRO $9.09
  • RCUS $10.63
  • Resistance Level
  • KRO $9.50
  • RCUS $13.49
  • Average True Range (ATR)
  • KRO 0.23
  • RCUS 0.77
  • MACD
  • KRO -0.06
  • RCUS -0.13
  • Stochastic Oscillator
  • KRO 5.98
  • RCUS 13.88

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in a variety of products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second-largest product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: